Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of extranodal natural killer (NK)/T-cell lymphoma

BACKGROUND: To explore a more effective treatment strategy for newly diagnosed stage I and II extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, we conducted a prospective phase II study of sequential chemoradiotherapy with the L-asparaginase, dexamethasone, ifosfamide, cisplatin, and et...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yao, Liu, Yizhen, Xia, Zuguang, Jin, Jia, Xue, Kai, Wang, Jiachen, Sun, Hui, Lv, Fangfang, Liu, Xiaojian, Cao, Junning, Hong, Xiaonan, Guo, Ye, Ma, Xuejun, Zhang, Qunling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350702/
https://www.ncbi.nlm.nih.gov/pubmed/34430619
http://dx.doi.org/10.21037/atm-21-3525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350702/
https://www.ncbi.nlm.nih.gov/pubmed/34430619
http://dx.doi.org/10.21037/atm-21-3525

Ejemplares similares